In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
about
Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal gangliaClass II major histocompatibility complex tetramer staining: progress, problems, and prospects.MHC-peptide tetramers for the analysis of antigen-specific T cells.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.
P2860
In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
description
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 18 April 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
In situ detection of antigen-s ...... ccination of melanoma patients
@en
In situ detection of antigen-s ...... ccination of melanoma patients
@nl
type
label
In situ detection of antigen-s ...... ccination of melanoma patients
@en
In situ detection of antigen-s ...... ccination of melanoma patients
@nl
prefLabel
In situ detection of antigen-s ...... ccination of melanoma patients
@en
In situ detection of antigen-s ...... ccination of melanoma patients
@nl
P2093
P2860
P50
P1476
In situ detection of antigen-s ...... ccination of melanoma patients
@en
P2093
De Vries IJ
Rombout PD
Scharenborg NM
Van Muijen GN
van Geloof WL
P2860
P2888
P304
P356
10.1007/S00262-007-0304-5
P577
2007-04-18T00:00:00Z